These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Antimicrobial resistance: time for action. Weese JS Vet Rec; 2011 Jul; 169(5):122-3. PubMed ID: 21803825 [No Abstract] [Full Text] [Related]
23. Variability of laboratory identification and antibiotic susceptibility reporting of Pseudomonas spp. isolates from dogs with chronic otitis externa. Schick AE; Angus JC; Coyner KS Vet Dermatol; 2007 Apr; 18(2):120-6. PubMed ID: 17355427 [TBL] [Abstract][Full Text] [Related]
24. Pseudomonas aeruginosa from canine otitis externa exhibit a quorum sensing deficiency. Tron EA; Wilke HL; Petermann SR; Rust L Vet Microbiol; 2004 Apr; 99(2):121-9. PubMed ID: 15019103 [TBL] [Abstract][Full Text] [Related]
25. Use of ticarcillin in the management of canine otitis externa complicated by Pseudomonas aeruginosa. Nuttall TJ J Small Anim Pract; 1998 Apr; 39(4):165-8. PubMed ID: 9577757 [TBL] [Abstract][Full Text] [Related]
26. Control of experimental burn wound infections: comparative delivery of the antimicrobial agent (silver sulfadiazine) either from a cream base or from a solid synthetic dressing. Robb EC; Nathan P J Trauma; 1981 Oct; 21(10):889-93. PubMed ID: 7277534 [TBL] [Abstract][Full Text] [Related]
27. [Local treatment of Pseudomonas aeruginosa infection of the external ear canal with the gyrase inhibitor Tarivid]. Hoffmann M Laryngorhinootologie; 1989 Nov; 68(11):643. PubMed ID: 2513817 [No Abstract] [Full Text] [Related]
28. Canine otitis externa: aetiological factors and a comparison of the therapeutic efficacy of certain drugs by in vitro and in vivo studies. Mathew Z; Murkibhavi GR; Mathew T Indian Vet J; 1970 Apr; 47(4):337-43. PubMed ID: 5423936 [No Abstract] [Full Text] [Related]
29. Evaluation of an ear cleanser for the treatment of infectious otitis externa in dogs. Cole LK; Kwochka KW; Kowalski JJ; Hillier A; Hoshaw-Woodard SL Vet Ther; 2003; 4(1):12-23. PubMed ID: 12756632 [TBL] [Abstract][Full Text] [Related]
30. Ear canal disease in the dog: medical and surgical management. Harvey CE J Am Vet Med Assoc; 1980 Jul; 177(2):136-9. PubMed ID: 7429946 [No Abstract] [Full Text] [Related]
31. Sulfadiazine silver-resistant Pseudomonas in Burns. New topical agents. Modak SM; Fox CL Arch Surg; 1981 Jul; 116(7):854-7. PubMed ID: 6455105 [TBL] [Abstract][Full Text] [Related]
33. Medical therapy of otitis externa and otitis media. Morris DO Vet Clin North Am Small Anim Pract; 2004 Mar; 34(2):541-55, vii-viii. PubMed ID: 15062623 [TBL] [Abstract][Full Text] [Related]
34. Silver sulfadiazine and Sulfamylon cream in the burned rat model: a comparative evaluation. Dressler DP; Skornik WA Surgery; 1970 Apr; 67(4):644-9. PubMed ID: 5435914 [No Abstract] [Full Text] [Related]
35. Clinical uses of gentamicin. Clark CH Mod Vet Pract; 1977 Sep; 58(9):751-4. PubMed ID: 335208 [No Abstract] [Full Text] [Related]
36. A laboratory method to evaluate formulation effects on the in vitro antimicrobial activity of topical creams and ointments. Love D; Kubey W; Holmes CJ Burns Incl Therm Inj; 1987 Jun; 13(3):204-7. PubMed ID: 3300889 [TBL] [Abstract][Full Text] [Related]
37. Otitis externa in the dog -- a clinical and microbiological study. Krogh HV; Linnet A; Knudsen PB Nord Vet Med; 1975 May; 27(5):285-95. PubMed ID: 807907 [TBL] [Abstract][Full Text] [Related]
38. The human pharmacology of silver sulphadiazine (AgSD). Fox CL Burns Incl Therm Inj; 1985 Apr; 11(4):306-7. PubMed ID: 4005650 [No Abstract] [Full Text] [Related]
39. Gentamicin in canine otitis externa. Houdeshell JW; Hennessey PW Vet Med Small Anim Clin; 1972 Jun; 67(6):625-8. PubMed ID: 4483136 [No Abstract] [Full Text] [Related]
40. Topical therapy and the development of silver sulfadiazine. Fox CL Surg Gynecol Obstet; 1983 Jul; 157(1):82-8. PubMed ID: 6857475 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]